Pediatric ID News

Over a period of 3 weeks, just after the end-of-the-year holidays, three healthy siblings presented with swollen lymph nodes.

A measles outbreak in Texas has climbed to nearly 60 cases in 3 weeks, with most cases occurring among unvaccinated children, according to state health officials.

The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 years against five meningococcal serogroups, the company announced.

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ease dengue virus symptoms when given before and after infection.

Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of rifampin-resistant tuberculosis, according to a study.

CDC data show that seasonal influenza activity is significantly elevated across the United States, and that influenza activity is at its highest level in more than 15 years.

Millions of children in Africa rely on funding from the United States for HIV care or testing — support that was threatened last month when President Donald J. Trump froze foreign aid spending after taking office.

MIAMI BEACH, Fla. — The recent FDA approvals of two treatments for molluscum contagiosum may represent a shift in how clinicians view this disease, according to a speaker at Masters of Pediatric Dermatology.

In 5 years, COVID-19 has impacted nearly every aspect of life. Although tens of thousands of cases continue to occur each week, the world’s top public health agencies have considered the pandemic phase of COVID-19 to be over for years.